Monday
September
29
2014
5:00 pm
Weather

  Home
  Local News
  State / National / World
  Sports
  Opinion / Letters
  Business
  Arts / Entertainment
  Lifestyle
  Obituaries
  Calendar
  Submit Event
  Comics / Games
  Classifieds
  DJ Designers
  Archives
  Advertise With Us
  About Us
 
 
 
 

Check out our archive of Dining Guides - Yum!

Proxy fight looms in Allergan-Valeant dispute
June 03, 2014, 05:00 AM The Associated Press

NEW YORK — Activist investor Bill Ackman says he will move to replace most of the board of directors of Allergan as part of a continuing battle for control of the company.

Ackman’s Pershing Square Capital Management and Canadian drugmaker Valeant Pharmaceuticals International Inc. want to buy Allergan, but the company has rejected their offers. Ackman says he wants to call a special shareholder meeting and will move to replace most of Allergan’s board members.

Ackman says the meeting could happen between early August and late November.

Botox-maker Allergan Inc. is urging shareholders to hold off taking action on Ackman’s proposal while the company’s board weighs the latest buyout proposal. Valeant and Pershing Square on Friday sweetened their offer to $53 billion in cash and Valeant stock.

 

 

Tags: allergan, valeant, board, ackman,


Other stories from today:

 

 
Print this Page Print this Page  |  Bookmark and Share
<< Back
 
Return To Archives
 
  


 
 
 
Daily Journal Quick Poll
 
Are you following the pro-democracy protests in Hong Kong?

Yes, very closely
Yes, a little
No, but I know I should
Not yet
Not at all

 

 
 
 
 
 
 
Police defend handling of protests in Hong Kong
HONG KONG — Police defended their use of tear gas and other methods to control the pro-democracy p..
Contracts to buy U.S. homes slide in August
WASHINGTON — Fewer Americans signed contracts to buy homes in August, suggesting that real estate ..
More >>  
 
 
  
 
  
 
©2014 San Mateo Daily Journal
San Mateo County blogs